For US Healthcare Professionals

I am a:

    • For US Healthcare Professionals

    Full Prescribing Information

    The TREMFYA® 8-week dosing schedule was optimized in clinical trials1,2

    Not actual size.

    Available in 2 dosage forms

    Prefilled syringe (NDC: 57894-640-01)

    One-Press patient-controlled injector (NDC: 57894-640-11)

    TREMFYA® is intended for use under the guidance and supervision of a physician. Patients may self-inject with TREMFYA® after physician approval and proper training. In active PsA, TREMFYA® may be administered alone or in combination with a conventional DMARD (eg, methotrexate).

    *Frequency of maintenance injections for TREMFYA® after the first year.

    DMARD=disease-modifying antirheumatic drug.

    References: 1. TREMFYA® (guselkumab) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc. 2. Lebwohl M, Langley RG, Zhu Y, et al. Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis. J Eur Acad Dermatol Venereol. 2019;33(11):2082-2086.

    One-Press patient-controlled injector

    TREMFYA® is the first and only anti–IL-23 with a patient-controlled, self-injection device; the patient controls the rate of delivery

    Not actual size.

    Device features designed with patients in mind

    • Can be used in physician's office or at home after physician approval and proper training
    • Needle guard keeps needle out of view
    • Soft “click” indicates when the injection is complete
    • Not made with natural rubber latex

    Please see the full Instructions for Use (IFU) for TREMFYA® One-Press patient-controlled injector.

    TREMFYA® is intended for use under the guidance and supervision of a physician. Patients may self-inject with TREMFYA® after physician approval and proper training.

    Injection demonstration videos

    Watch these easy-to-follow injection demonstration videos for TREMFYA®.

    The injection demonstration videos are not meant to replace the IFU that are supplied with TREMFYA®. Instruct patients to read the IFU before using their TREMFYA® prefilled syringe or One-Press injector and each time they get a refill.

    Download instructions for use

    TREMFYA® is intended for use under the guidance and supervision of a physician. Patients may self-inject with TREMFYA® after physician approval and proper training.